Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization

Vaccine

Volumn 19, Issue 27, 2001, Pages 3778-3786

  Reyes, Luane ^a   Hartikka, Jukka ^a   Bozoukova, Vesselina ^a   Sukhu, Loretta ^a   Nishioka, Walter ^a   Singh, Gita ^a   Ferrari, Marilyn ^a   Enas, Joel ^a   Wheeler, Carl J ^a   Manthorpe, Marston ^a   Wloch, Mary K ^a  

^a VICAL INC   (United States)

Author keywords

Adjuvant; Cationic lipid; DNA vaccine

Indexed keywords

ANTIGEN; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; INTERLEUKIN 6; PLASMID DNA; UNCLASSIFIED DRUG; VAXFECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY SPECIFICITY; CYTOKINES; DRUG CARRIERS; ETHANOLAMINES; FEMALE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MYRISTIC ACIDS; PLASMIDS; TH1 CELLS;

EID: 0035859294     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00090-1     Document Type: Article

References (56)

1. Direct gene transfer into mouse muscle in vivo
2. Bovine herpesvirus 1: Immune responses in mice and cattle injected with plasmid DNA
3. Direct gene transfer in skeletal muscle: Plasmid DNA-based immunization against the hepatitis B virus surface antigen
4. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein
5. Heterologous protection against influenza by injection of DNA encoding a viral protein
6. Out on the farm with DNA vaccines
7. DNA vaccines
8. Genes that induce immunity-DNA vaccines
9. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization
10. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA
11. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
12. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response
13. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans
14. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
15. An improved plasmid DNA expression vector for direct injection into skeletal muscle
16. Sodium phosphate enhances plasmid DNA expression in vivo
17. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction
18. DNA Immunization: Ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction
19. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T lymphocytes
20. Selected strategies to augment polynucleotide immunization
21. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes
22. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens
23. HIV-1 DNA vaccines and chemokines
24. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1
25. DNA vaccination of mice against rabies virus: Effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL)
26. Adjuvants for plasmid DNA vaccines
27. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1
28. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes
29. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody
30. Enhancement of DNA vaccine potency using conventional aluminum adjuvants
31. Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum-phosphate
32. Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens
33. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously
34. IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile
35. B cell growth and differentiation activity of interleukin-HP1 and related murine plasmacytoma growth factors. Synergy with interleukin 1
36. Current concepts of B cell modulation
37. Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin
38. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma
39. Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA
40. Cancer gene therapy using plasmid DNA: Purification of DNA for human clinical trials
41. Bone marrow is a major site of long-term antibody production after acute viral infection
42. The expanding universe of T-cell subsets: Th1, Th2 and more
43. Give us this day our daily germs
44. Immune activation by bacterial DNA: A new genetic code
45. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12, and IFN
46. Rapid immune activation by CpG motifs in bacterial DNA: Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway
47. Effects of bacterial DNA on cytokine production by (NZB/NZW)F1 mice
48. Interleukin-6: An overview
49. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system
50. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
51. CpG motifs in bacterial DNA trigger direct B-cell activation
52. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry
53. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung
54. Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats
55. Cancer gene therapy using plasmid DNA: Safety evaluation in rodents and non-human primates
56. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans